Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $35.0000 (-2.78%) ($32.5000 - $36.0000) on Fri. Nov. 8, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.62% (three month average) | RSI | 51 | Latest Price | $35.0000(-2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(5%) PEJ(5%) EWP(4%) XAR(4%) XOP(4%) | Factors Impacting CAPR price | CAPR will decline at least -5.81% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.81% (StdDev 11.62%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
Resistance Level | $36.57 | 5 Day Moving Average | $36.2(-3.31%) | 10 Day Moving Average | $35.16(-0.46%) | 20 Day Moving Average | $36.57(-4.29%) | To recent high | -24.7% | To recent low | 133.3% | Market Cap | $689m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |